Bausch Health Companies

Yahoo Finance • 2 months ago

Bausch Health Companies Inc. (BHC): Among Billionaire Carl Icahn’s Top Stock Picks

We recently compiled a list of the Billionaire Carl Icahn's Top 10 Stocks.In this article, we are going to take a look at where Bausch Health Companies Inc. (NYSE:BHC) stands against Carl Icahn's top stock picks. One would expect legendar... Full story

Yahoo Finance • 6 months ago

Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript

Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript May 2, 2024 Bausch Health Companies Inc. misses on earnings expectations. Reported EPS is $0.59 EPS, expectations were $0.75. Bausch Health Companies Inc. isn’t one... Full story

Yahoo Finance • 7 months ago

10 Best Healthcare Stocks to Buy Under $20

In this article, we will be taking a look at the 10 best healthcare stocks to buy under $20. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Best Healthcare Stocks to Buy Under $20. Global Healthca... Full story

Yahoo Finance • 8 months ago

14 Best Canadian Stocks To Buy and Hold In 2024

In this article, we discuss 14 best Canadian stocks to buy for 2024. If you want to skip our discussion on the Canadian economy, head over to 5 Best Canadian Stocks To Buy and Hold In 2024. Despite concerns about high inflation and rising... Full story

Yahoo Finance • 9 months ago

Salix Announces 2024 Gastrointestinal Health Scholars Program

Salix to Provide Scholarships to 10 Students Living with GI Diseases LAVAL, QC / ACCESSWIRE / February 12, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the opening of the 2024 Salix Gastrointestinal Health Schol... Full story

Yahoo Finance • 9 months ago

A 'Toxic Byproduct of an Imperfect Higher Education System' — Famous Short Seller Known as 'The Assassin' Strikes Her Newest Target

Fahmi Quadir, featured in the Netflix series "Dirty Money" for her success in predicting and betting on the collapse of Valeant Pharmaceuticals International Inc. (now known as Bausch Health Cos. Inc. (NYSE: BHC), is taking on Adtalem Glob... Full story

Yahoo Finance • 10 months ago

Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute

LAVAL, QC / ACCESSWIRE / January 8, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, as scheduled, oral arguments were heard today at the U.S. Court of... Full story

Yahoo Finance • 11 months ago

Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis

Trial Meets Both Primary and Key Secondary Endpoints LAVAL, QC / ACCESSWIRE / December 21, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced positive topline results from the Compan... Full story

Yahoo Finance • 12 months ago

Is Bausch + Lomb Corporation (NYSE:BLCO) Trading At A 39% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Bausch + Lomb fair value estimate is US$25.50 Current share price of US$15.64 suggests Bausch + Lomb is potentially 39% undervalued The US$20.58 analyst price target for BLCO is 19%... Full story

Yahoo Finance • last year

13 Best Canadian Stocks to Buy and Hold

In this article, we will take a look at the 13 best Canadian stocks to buy and hold. To see more such companies, go directly to 5 Best Canadian Stocks to Buy and Hold. The Canadian economy is also facing the heat of inflation and rising i... Full story

Yahoo Finance • last year

New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence

Hurdles Led to Almost All Patients Having At Least One Day Delay to Receive Treatment with Xifaxan® LAVAL, QC / ACCESSWIRE / October 17, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business, Salix Phar... Full story

Yahoo Finance • last year

Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.

Salix Pharmaceuticals' Liver Health Annual Trends Report Findings Suggest Chronic Liver Disease (CLD) Deaths Could Triple Before the End of the Decade Based Primarily on HCP-Market Research, Report Finds a Growing Concern of Staffing Short... Full story

Yahoo Finance • last year

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch” or the “Company”) (NYSE: BHC). Such investors are advised to contact Robert S. Willoughby... Full story

Yahoo Finance • last year

DEADLINE ALERT for BHC, SYNH, ALDX, EOSE: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM, Pa., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story

Yahoo Finance • last year

DEADLINE ALERT for RIDE/RIDEQ, BHC, SYNH, and ALDX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story

Yahoo Finance • last year

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bausch Health Companies Inc. (BHC)

LOS ANGELES, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 25, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purcha... Full story

Yahoo Finance • last year

BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.

NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own securities of Bausch Health Companies Inc. (NYSE: BHC)? Did you purchase your securities between August 6, 2020 and May 3, 2023, inclusive? D... Full story

Yahoo Finance • last year

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Bausch Investors of a Lead Plaintiff Deadline of September 25, 2023

NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Attention Bausch Health Companies Inc. ("Bausch") (NYSE: BHC) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purch... Full story

Yahoo Finance • last year

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Live Nation, Bausch, and Applied Digital and Encourages Investors to Contact the Firm

NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Live Nation Entertainmen... Full story

Yahoo Finance • last year

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch” or the “Company”) (NYSE: BHC). Such investors are advised to contact Robert S. Willoughby... Full story